Tech Center 1600 • Art Units: 1611
This examiner grants 36% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17796586 | ANTIMICROBIAL COATING | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18753538 | COMPRESSED TABLETS | Non-Final OA | DSM IP Assets B.V. |
| 18543157 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND ADDITIONAL ORGANIC UV FILTER(S) | Non-Final OA | L'OREAL |
| 17885098 | MINERAL SUNSCREEN COMPOSITIONS | Final Rejection | L'OREAL |
| 18569116 | ANTIBACTERIAL COMPOSITION COMPRISING TRANSITION METAL DICHALCOGENIDE AS AN ACTIVE INGREDIENT | Non-Final OA | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS |
| 18561664 | GLITTER PIGMENT INCLUDING ZIRCONIUM-OXIDE-INCLUDING COATING | Non-Final OA | Nippon Sheet Glass Company, Limited |
| 18577138 | METHOD FOR DYEING KERATINOUS MATERIAL, INCLUDING THE APPLICATION OF AN ORGANOSILICON COMPOUND, POLYETHYLENE GLYCOLS, A DYEING COMPOUND, AND AN AFTERTREATMENT AGENT | Non-Final OA | HENKEL AG & CO. KGAA |
| 17150520 | DEGRADABLE MICROPARTICLE, DEGRADABLE PRODUCT COMPRISING THE SAME AND APPLICATION THEREOF | Non-Final OA | National Tsing Hua University |
| 17710076 | AGGLOMERATED BOTANICAL MATERIAL FOR ORAL PRODUCTS | Non-Final OA | R.J. Reynolds Tobacco Company |
| 17800554 | USE OF MICA IN PRESSED POWDER | Final Rejection | IMERTECH SAS |
| 17785207 | ISOLATED OLEOSOME COMPOSITION AND PROCESS FOR PREPARING IT | Non-Final OA | CARGILL, INCORPORATED |
| 17913422 | SURFACE-TREATED METAL OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC AND METHOD FOR PRODUCING SURFACE-TREATED METAL OXIDE PARTICLES | Final Rejection | SUMITOMO OSAKA CEMENT CO., LTD. |
| 18274020 | COSMETIC HAVING TITANIUM DIOXIDE IN THE AQUEOUS PHASE | Non-Final OA | BEIERSDORF AG |
| 18686696 | OCULAR DEVICE AND METHODS | Non-Final OA | Vinci Pharmaceuticals, Inc. |
| 18573514 | SYSTEM FOR TRANSPORTING AND DELIVERING OF NITRIC OXIDE | Non-Final OA | YES2NO GMBH |
| 18391665 | HALLOYSITE-BASED COMPOSITE HEMOSTATIC MATERIAL AND PREPARATION METHOD AND USE THEREOF | Non-Final OA | CHINA UNIVERSITY OF GEOSCIENCES (WUHAN) |
| 18001382 | ANTIMICROBIAL FORMULATIONS COMPRISING SILICONE | Final Rejection | AMICOAT AS |
| 18321856 | HERBAL COMPOSITION JCM-16021 AS TREATMENT FOR INFLAMMATORY BOWEL DISEASE | Non-Final OA | University of Macau |
| 18280205 | USE OF COLLAGEN PARTICLES IN HAIR FOLLICLES FORMATION OR ANGIOGENESIS | Final Rejection | Acro Biomedical Company. Ltd. |
| 17783086 | Starch-Based Fluffy Particle, Preparation Method and Use Thereof | Final Rejection | HONEST MEDICAL CHINA CO., LTD. |
| 18257440 | USE OF BACTERIORUBERINS AND GLYCOSYL DERIVATIVES THEREOF TO PREVENT AND TREAT DISEASES INVOLVING DYSREGULATED PROTEIN AGGREGATION, SUCH AS NEURODEGENERATIVE DISEASES | Non-Final OA | Miroslav RADMAN |
| 18297841 | COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION | Final Rejection | Xygenyx Inc. |
| 18022760 | ARTHROSPIRA FOR USE IN THE TREATMENT OF DISEASES | Non-Final OA | BRANDENBURGISCHE TECHNSCH UNIVERSITÄT COTTBUS-SENFTENBERG |
| 18006165 | USE OF AN ACTIVATED CARROT FIBER FOR PRODUCING PRODUCTS | Final Rejection | Herbstreith & Fox GmbH & Co. KG Pektin- Fabriken |
| 17970702 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MUSCLE SORENESS AND FOOT & JOINT PAIN | Non-Final OA | Spraingo, LLC |
| 17899157 | DIHYDROMYRICETIN NANOPARTICLE FORMULATIONS | Non-Final OA | Cheers Health, Inc. |
| 17904965 | AN ACTIVATABLE WOUND DRESSING | Final Rejection | AGA Nanotech Ltd |
| 17295934 | WHITE PINE BARK EXTRACT FOR DECREASING ENDOTHELIN-1 SECRETION, STEM CELL FACTOR SYNTHESIS AND PROTEIN CARBONYLATION | Final Rejection | LUCAS MEYER COSMETICS |
| 16972727 | METHOD FOR PREPARING COMPOSITION COMPRISING KILLED OR INACTIVATED METHANOBREVIBACTER ARCHAEBACTERIA CELLS AND COMPOSITION THEREBY OBTAINED | Non-Final OA | Duncan-Bruce SUTHERLAND |
| 16513068 | EXTENDED RELEASE FORMULATIONS OF CANNABINOIDS | Final Rejection | Glatt GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy